Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 1,726 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Physical Activity Level Clear all

Conditions: Type 2 Diabetes Mellitus
Interventions: Ranolazine, Placebo to match ranolazine, Metformin, Placebo to match metformin, Diet, Exercise; Drug · Behavioral
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 60
States / cities: Gulf Shores, Alabama • Little Rock, Alaska • Chandler, Arizona + 53 more

Conditions: HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency, Lymphoid Tissue; Infection, Interleukin
Interventions: FT538, Vorinostat; Biological · Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Amyotrophic Lateral Sclerosis (ALS), Neuromuscular Diseases
Interventions: Acute Intermittent Hypoxia, Sham Acute Intermittent Hypoxia; Other
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Cancer, Neoplasm
Interventions: SAR444881, Pembrolizumab, Cetuximab, Carboplatin, Pemetrexed; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 9
States / cities: Phoenix, Arizona • Duarte, California • Aurora, Colorado + 6 more

Conditions: Cardiovascular
Interventions: quasi-experimental Pre-test/Post-test design; Behavioral
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Mansfield, Texas

Conditions: Hepatocellular Carcinoma
Interventions: Exercise intervention; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 69 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Obesity, Overweight, Insulin Resistance
Interventions: Neuromuscular Electrical Stimulation (Sensory), Neuromuscular Electrical Stimulation, Resistance Training; Device · Other
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Osteoarthritis of the Knee
Interventions: Social Incentives and Gamification to Promote Exercise, Corticosteroid Injection given in A-B order, No Social Incentive applied, Corticosteroid Injection given in B-A order; Behavioral · Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 80 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer Female
Interventions: The Behavioral Activation/ Problem Solving Intervention, Attention Control Condition; Behavioral
Lead sponsor: MGH Institute of Health Professions; Other
Eligibility: 18 Years and older · Female only
Enrollment: 303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Birmingham, Alabama • Lebanon, New Hampshire

Conditions: Chronic Pain, Back Pain, Back Pain Lower Back Chronic, Neck Pain
Interventions: Pain reprocessing therapy (PRT), Cognitive Behavioral Therapy for Chronic Pain (CBT-CP), Usual Care; Behavioral · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Insulin Resistance, Impaired Glucose Tolerance, Obesity, Metabolic Disturbance
Interventions: Low Physical Activity and Added Carbohydrate Group, Low physical Activity Control, High Physical Activity and Added Carbohydrate Group; Behavioral
Lead sponsor: University of New Hampshire; Other
Eligibility: 18 Years to 30 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Durham, New Hampshire

Conditions: Muscle Injury
Interventions: Healthy Muscle Group, Stretch-Contract Pre-rehabilitation Group, Stretch-Contract Control Group, Muscle Atrophy; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 40 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Sedentary Lifestyle
Interventions: Senior Change Makers Advocacy Program, Senior Change Makers Physical Activity Program; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Physical Activity
Interventions: Your Move (physical activity), Your Money (financial empowerment); Behavioral · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older · Male only
Enrollment: 628 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Durham, North Carolina

Conditions: Advanced Cancer
Interventions: PTC299, Docetaxel; Drug
Lead sponsor: PTC Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Metabolic Disorders, Physical Inactivity, Vascular Disease Risk
Interventions: reduced physical activity; Other
Lead sponsor: Miami University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Oxford, Ohio

Conditions: Breast Cancer
Interventions: Baseline Fitness Test, Questionnaires, Individualized Exercise Program, Written Materials; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke, Hemiplegic Gait
Interventions: Skateboard exercise at an incline angle of 0 degrees and 50% body weight, Skateboard exercise at an incline angle of 5 degrees and 50% body weight, Skateboard exercise at an incline angle determined to be optimal in phase 1 (either 0 or 5 degrees) and 75% body weight, Skateboard exercise at an incline angle determined to be optimal in phase 1 (either 0 or 5 degrees) and 90% body weight, Control 4-week exercise intervention, Experimental 4-week exercise intervention, Over-ground multi-directional gait training, Home exercise; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HIV Infection
Interventions: Polyphenon E, Placebo; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Spinal Cord Injury
Interventions: A&L cycling, Body weight supported treadmill training (BWSTT); Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Knee Osteoarthritis
Interventions: Wearable sensor-based exercise training; Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Diastasis Recti, Postpartum, Low Back Pain
Interventions: Core Muscle Strength Training; Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Weight Gain, Eating Disorders
Interventions: Healthy Weight, Project Health, Placebo Control; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 17 Years to 23 Years
Enrollment: 364 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 4
States / cities: Corvallis, Oregon • Eugene, Oregon • Austin, Texas

Conditions: Oncology, Melanoma, Ovarian Cancer, NSCLC, Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Cancer, CRC, Colon Cancer, Breast Cancer, Gastric Cancer, EGJ, Esophagogastric Junction Cancer, Head and Neck Cancer, Urothelial Cancer, Bladder Cancer
Interventions: E-602, Cemiplimab; Biological
Lead sponsor: Palleon Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 13
States / cities: La Jolla, California • Los Angeles, California • Stanford, California + 10 more

Search by objective public record fields.

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors

Association of Wearable Activity Monitors With Post-Operative Activity Level Among Cardiovascular Surgical Patients

EXALT: EXercise Attenuates Liver Tumors Trial

Improving Glycemic Control With Electrical Stimulation

A Pragmatic Trial To Determine the Benefit of Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee

Optimizing Functional Recovery of Breast Cancer Survivors

Psychological Options for Wellness and Recovery (POWeR) Trial for Veterans With Chronic Back/Neck Pain

The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults

Muscle Injury Prevention & Rehabilitation in Military Personnel

Senior Change Makers Study: Improving Physical Activity Environments

FITShop: Promoting Physical Activity in Black Barbershops

PTC299 for Treatment of Advanced Cancer

Interactive Roles of Cardiorespiratory Fitness and Adiposity on Glucose and Vascular Control After Physical Inactivity

Part II: Exercise in Hispanic Breast Cancer Survivors

The Effects of Plantar Flexion Training in People With Chronic Stroke

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

Arm and Leg Cycling for Accelerated SCI Recovery

Wearable Sensor-based Balance Training for Patients With Knee Osteoarthritis

Core Strengthening for DRA in Postpartum Women

Effectiveness Trial of a Dissonance-Based Obesity Prevention Program

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)